Vimarsana
Biggest News Aggregation in the World

Page 25 - Ohnson Johnson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ohnson Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ohnson Johnson Today - Breaking & Trending Today

Johnson & Johnson must pay $302 million for deceptive marketing of pelvic mesh implants, court rules - Vimarsana News

Johnson & Johnson must pay $302 million for deceptive marketing of pelvic mesh implants, court rules

Published: April 12, 2022

A state court said Johnson & Johnson must pay California $302 million for many years...

Source: sfchronicle.com
Related Topics:
United StatesDistrict Of ColumbiaXavier BecerraRyan CarbainRob BontaJustice Judith McconnellSupreme CourtDepartment Of JusticeHuman ServicesDrug AdministrationSuperior Court Judge Eddie SturgeonGeneral Rob BontaPresident BidenJudith McconnellEddie SturgeonRyan CarbainOb EgelkoXavier BecerraBay AreaSan Diego CountyDistrict Of ColumbiaOhnson JohnsonFourth District Court Of AppealSupreme CourtHealth And Human Services
Texas court halts abuse inquiries into parents of transgender children - Vimarsana News

Texas court halts abuse inquiries into parents of transgender children

Published: March 12, 2022

Texas court halts abuse inquiries into parents of transgender children

Source: bdnews24.com
Related Topics:
New YorkUnited StatesTravis CountyCourtney CorbelloAmy Clark MeachumMegan MooneyJane DoeMary DoeRanda MulanaxBrian KlosterboerKaren LoewyKen PaxtonLevi Strauss CoYork Times CompanyServices Under AbbottDepartment Of FamilyAmerican Civil Liberties UnionJudge Amy Clark MeachumProtective ServicesLambda LegalAmerican Civil LibertiesTexas ChildrenLevi StraussTexas Attorney General Ken PaxtonNew York Times
Advertiser.ie - Leading stroke care company CERENOVUS announces €50 million investment in Ballybrit site - Vimarsana News

Advertiser.ie - Leading stroke care company CERENOVUS announces €50 million investment in Ballybrit site

Published: February 16, 2022

CERENOVUS, a leading MedTech company specialising in stroke research and care, has this week announced a €50 million investment in its Galway site, leading to 30 new specialised jobs at the Ballybrit facility.

Source: advertiser.ie
Related Topics:
Simon HarrisMichael GilvarryJohnson Medical DevicesHigher EducationScience Simon HarrisGeography Of IrelandGalway Mayo Institute Of TechnologyAdministrative DivisionsHealth Medical PharmaGeneral ManagerTechnology InternetMedical TechnologySimon HarrisOhnson JohnsonMedical DevicesMedical Equipment WholesaleMichael GilvarryStroke CareLife SciencesStroke TreatmentHarmaceuticals NecAllybrit FacilityIschemic StrokeStroke SolutionsDifferentiated Solutions
J&J pauses production of its COVID-19 vaccine: NYT - Vimarsana News

J&J pauses production of its COVID-19 vaccine: NYT

Published: February 8, 2022

J&J pauses production of its COVID-19 vaccine: NYT

Source: bdnews24.com
Related Topics:
United StatesNew YorkSouth AfricaNorth CarolinaWhite HouseDistrict Of ColumbiaSeth BerkleyAspen PharmacareJake SargentMatt HartwigStephen SaadAyoade AlakijaYork Times CompanyWorld Health OrganizationDrug AdministrationNew York TimesAfrican UnionPenny HeatonEmergent BiosolutionsModerna IncThe Vaccine AllianceVaccination And ImmunisationChronic ConditionUnited StatesActories And Manufacturing
Younger Americans benefited less from booster shots than older people - Vimarsana News

Younger Americans benefited less from booster shots than older people

Published: February 5, 2022

Younger Americans benefited less from booster shots than older people

Source: bdnews24.com
Related Topics:
New YorkUnited StatesBeth Israel Medical CenterUnited KingdomDan BarouchJohn MooreYork Times CompanyKaiser Health NewsBeth Israel Deaconess Medical CenterKaiser HealthWeill Cornell MedicineNew York TimesYounger AmericansBooster ShotsOlder PeopleNder Age 50Ospitalisation And DeathCdc DataModerna IncVaccination And ImmunisationOronavirus Delta Variant ChronicOndition Health United StatesEath And DyingDrugs Pharmaceuticals